Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)
CNY 30.06
(0.2%)
CNY 30.06
(0.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 300 Million CNY | 281.46% |
| 2022 | 78.64 Million CNY | 521.62% |
| 2021 | 12.65 Million CNY | 345.81% |
| 2020 | 2.83 Million CNY | -56.79% |
| 2019 | 6.56 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 61 Million CNY | -100.0% |
| 2024 Q2 | 53.5 Million CNY | 0.0% |
| 2024 Q3 | 53.16 Million CNY | 0.0% |
| 2023 Q1 | 421.43 Million CNY | 435.87% |
| 2023 FY | 300 Million CNY | 281.46% |
| 2023 Q4 | 300 Million CNY | -19.78% |
| 2023 Q3 | 373.95 Million CNY | -0.35% |
| 2023 Q2 | 375.28 Million CNY | -10.95% |
| 2022 Q2 | 28.72 Million CNY | 50.67% |
| 2022 Q1 | 19.06 Million CNY | 50.71% |
| 2022 FY | 78.64 Million CNY | 521.62% |
| 2022 Q4 | 78.64 Million CNY | 5.58% |
| 2022 Q3 | 74.49 Million CNY | 159.29% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 FY | 12.65 Million CNY | 345.81% |
| 2021 Q2 | 17.8 Million CNY | 0.0% |
| 2021 Q3 | 20.74 Million CNY | 16.56% |
| 2021 Q4 | 12.65 Million CNY | -39.02% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | 2.83 Million CNY | -56.79% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | -100.0% |
| 2020 Q1 | 6.65 Million CNY | 1.33% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q4 | 6.56 Million CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 6.56 Million CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |